Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

by Jillian McKoy, Michael Saunders,Boston UniversityCredit: CC0 Public DomainSince August 2018, the US Food & Drug Administration has mandated that all hookah (also known as waterpipe tobacc

Updated on: April 23,2024 19

Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

by Jillian McKoy, Michael Saunders,Boston UniversityCredit: CC0 Public DomainSince August 2018, the US Food & Drug Administration has mandated that all hookah (also known as waterpipe tobacc

Updated on:April 23,2024 19

Lorazepam may Fuel Poor Pancreatic Cancer Outcome!

byHemalatha Manikandanon August 17, 2023Lorazepamis a drug, frequently used to relieve anxiety in cancer patients. Studies reveal that,Pancreatic cancerpatients who took

Updated on: December 19,2023 24

Lorazepam may Fuel Poor Pancreatic Cancer Outcome!

byHemalatha Manikandanon August 17, 2023Lorazepamis a drug, frequently used to relieve anxiety in cancer patients. Studies reveal that,Pancreatic cancerpatients who took

Updated on:December 19,2023 24

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p

Updated on: December 22,2023 22

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p

Updated on:December 22,2023 22

Noninvasive technique to assess brain tumors in children and make treatment less toxic

by Chris Speight,University of BirminghamCredit: CC0 Public DomainGround-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhoo

Updated on: December 20,2023 24

Noninvasive technique to assess brain tumors in children and make treatment less toxic

by Chris Speight,University of BirminghamCredit: CC0 Public DomainGround-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhoo

Updated on:December 20,2023 24

Cancer researchers find that tumors' metabolism is slower than suspected

by Wendy Plump,Princeton UniversityCredit: Pixabay/CC0 Public DomainScientists have never known precisely how much energy a cancerous tumor expends growing in the mammalian body.They hypothesize

Updated on: December 18,2023 10

Cancer researchers find that tumors' metabolism is slower than suspected

by Wendy Plump,Princeton UniversityCredit: Pixabay/CC0 Public DomainScientists have never known precisely how much energy a cancerous tumor expends growing in the mammalian body.They hypothesize

Updated on:December 18,2023 10

RXR, the cell protein that keeps blood stem cells young and fit

RXR, the cell protein that keeps blood stem cells young and fitby Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Bone marrow histology in a normal mouse and in a mouse lacking

Updated on: October 29,2023 10

RXR, the cell protein that keeps blood stem cells young and fit

RXR, the cell protein that keeps blood stem cells young and fitby Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Bone marrow histology in a normal mouse and in a mouse lacking

Updated on:October 29,2023 10

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

October 21, 2023Gina MauroSelpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients

Updated on: October 24,2023 2

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

October 21, 2023Gina MauroSelpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients

Updated on:October 24,2023 2

Scientists find strong evidence for testing newly developed drug in liver cancer

byVirginia Commonwealth UniversityDevanand Sarkar, M.B.B.S., Ph.D. Credit: VCU Massey Cancer CenterResearchers at VCU Massey Cancer Center have published new study findings that establish ration

Updated on: December 27,2023 10

Scientists find strong evidence for testing newly developed drug in liver cancer

byVirginia Commonwealth UniversityDevanand Sarkar, M.B.B.S., Ph.D. Credit: VCU Massey Cancer CenterResearchers at VCU Massey Cancer Center have published new study findings that establish ration

Updated on:December 27,2023 10

Australian scientists closer to finding new lung cancer treatments

byAustralian National UniversityAssociate Professor Marian Burr. Credit: Jamie Kidston/ANUScientists from The Australian National University (ANU) and the Peter MacCallum Cancer Centre have disc

Updated on: December 19,2023 12

Australian scientists closer to finding new lung cancer treatments

byAustralian National UniversityAssociate Professor Marian Burr. Credit: Jamie Kidston/ANUScientists from The Australian National University (ANU) and the Peter MacCallum Cancer Centre have disc

Updated on:December 19,2023 12

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on: December 17,2023 10

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on:December 17,2023 10

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in

Updated on: December 22,2023 10

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in

Updated on:December 22,2023 10

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

About one-fifth of often deadly head and neck cancers harbor genetic mutations in a pathway that is key to normal cell growth, and scientists report those mutations, which enable abnormal cancer cell

Updated on: October 27,2023 25

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

About one-fifth of often deadly head and neck cancers harbor genetic mutations in a pathway that is key to normal cell growth, and scientists report those mutations, which enable abnormal cancer cell

Updated on:October 27,2023 25